Merck Announces First-Quarter 2023 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/26/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Fox Factory sells Marucci Sports for $225M, cuts debt
Merck (MRK) Tops Q1 EPS by 5c; Offers FY23 Guidance
April 27, 2023 6:35 AM EDTMerck (NYSE: MRK) reported Q1 EPS of $1.40, $0.05 better than the analyst estimate of $1.35. Revenue for the quarter came in at $0 versus the consensus estimate of $13.78 billion.
GUIDANCE:
Merck sees FY2023 EPS of $6.88-$7.00, versus the consensus of $6.91. Merck sees FY2023... More
